Funds managed by Invesco Asset Management Limited invest in Gelesis
Client(s) Invesco Asset Management Limited
Jones Day advised Invesco Asset Management Limited in connection with its equity investment in Gelesis, Inc., a clinical stage biotechnology company focused on the development of first-in-class products to safely induce weight loss and improve glycemic control.